Cleared Traditional

K073156 - QPLAQUE MR

K073156 is the FDA 510(k) clearance for QPLAQUE MR by Medis Medical Imaging Systems BV. It is a Class 2 Radiology device (product code LNH) cleared through the Traditional 510(k) pathway after a 117-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
117d
Days
Class 2
Risk

K073156 is an FDA 510(k) clearance for the QPLAQUE MR. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Medis Medical Imaging Systems BV (Leiden, NL). The FDA issued a Cleared decision on March 4, 2008 after a review of 117 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medis Medical Imaging Systems BV devices

Submission Details

510(k) Number K073156 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 2007
Decision Date March 04, 2008
Days to Decision 117 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 107d · This submission: 117d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 813
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K073156.
GE SIGNA MR ONCOLOGY PACKAGE
K081916 · Ge Medical Systems, LLC · Jul 2008
S-SCAN, G-SCAN, DYNAMIC MRI SOFTWARE FOR C-SCAN, E-SCANXQ & E-SCAN OPERA
K080968 · Esaote, S.P.A. · Apr 2008
SIGNA 3.0T MR750 SYSTEM
K081028 · Ge Medical Systems, LLC · Apr 2008
VANTAGE TITAN, MODEL MRT-1504/S3
K080038 · Toshiba America Medical Systems, In.C · Jan 2008
BRAINSTAT SOFTWARE OPTION FOR GE SIGNA MR SCANNER
K073167 · Ge Medical Systems, LLC · Jan 2008
JET SOFTWARE FOR EXCELART VANTAGE ATLAS-Z AND ATLAS-X
K073081 · Toshiba America Medical Systems, In.C · Nov 2007